Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
Johnson and Johnson
Boehringer Ingelheim
Medtronic

Last Updated: May 25, 2022

Drug Sales Trends for METFORMIN ER


✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for METFORMIN ER (2019)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $44,418,356
INSIDE HMO/CLINIC/HOSPITAL $226,109
[disabled in preview] $94,626,556
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 30,857
INSIDE HMO/CLINIC/HOSPITAL 12,943
[disabled in preview] 231,371
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
PRIVATE INSURANCE $136,405,123
SELF OR FAMILY $2,704,503
[disabled in preview] $161,396
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for METFORMIN ER
Drug Units Sold Trends for METFORMIN ER

Annual Sales Revenues and Units Sold for METFORMIN ER

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
METFORMIN ER See Plans and Pricing See Plans and Pricing 2019
METFORMIN ER See Plans and Pricing See Plans and Pricing 2018
METFORMIN ER See Plans and Pricing See Plans and Pricing 2017
METFORMIN ER See Plans and Pricing See Plans and Pricing 2016
METFORMIN ER See Plans and Pricing See Plans and Pricing 2015
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Colorcon
McKesson
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.